phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with bivalirudin in 6 studies
| Studies (phenylalanyl-prolyl-arginine-chloromethyl ketone) | Trials (phenylalanyl-prolyl-arginine-chloromethyl ketone) | Recent Studies (post-2010) (phenylalanyl-prolyl-arginine-chloromethyl ketone) | Studies (bivalirudin) | Trials (bivalirudin) | Recent Studies (post-2010) (bivalirudin) |
|---|---|---|---|---|---|
| 191 | 4 | 23 | 1,323 | 263 | 709 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cicala, C; Emerson, M; Liu, JT; Page, CP; Paul, W | 1 |
| Brash, JL; Kinlough-Rathbone, RL; Rubens, FD; Weitz, JI | 1 |
| Fenton, JW | 1 |
| Prasa, D; Stürzebecher, J; Svendsen, L | 1 |
| Deinum, J; Elg, M; Gustafsson, D | 1 |
| Grabau, R; Palekar, R; Pan, H; Vargas, I; Wickline, SA; Wilson, AJ; Zhou, Q | 1 |
1 review(s) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and bivalirudin
| Article | Year |
|---|---|
Thrombin functions and antithrombotic intervention.
Topics: Amino Acid Chloromethyl Ketones; Amino Acid Sequence; Animals; Antithrombins; Blood Coagulation; Cricetinae; Hirudin Therapy; Hirudins; Mice; Models, Molecular; Molecular Sequence Data; Peptide Fragments; Rats; Receptors, Thrombin; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Species Specificity; Substrate Specificity; Thrombin; Thrombosis | 1995 |
5 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and bivalirudin
| Article | Year |
|---|---|
Thrombin inhibitors and anti-coagulants on thrombin-induced embolisation in rabbit cranial vasculature.
Topics: Amino Acid Chloromethyl Ketones; Animals; Anticoagulants; Antithrombins; Blood Platelets; Boron Compounds; Dalteparin; Dose-Response Relationship, Drug; Fibrinolytic Agents; Heparin; Hirudin Therapy; Hirudins; Indium; Infusions, Intra-Arterial; Intracranial Embolism and Thrombosis; Isotope Labeling; Male; Molecular Weight; Oligopeptides; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Circulation; Rabbits; Recombinant Proteins; Structure-Activity Relationship; Thrombin | 1994 |
The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
Topics: Amino Acid Chloromethyl Ketones; Amino Acid Sequence; Antithrombin III; Blood Vessel Prosthesis; Fibrin; Heparin; Hirudins; Humans; In Vitro Techniques; Microscopy, Electron, Scanning; Molecular Sequence Data; Peptide Fragments; Polyethylenes; Recombinant Proteins; Surface Properties; Thrombin; Thrombosis | 1993 |
The ability of thrombin inhibitors to reduce the thrombin activity generated in plasma on extrinsic and intrinsic activation.
Topics: Amino Acid Chloromethyl Ketones; Antithrombins; Binding Sites; Blood Coagulation; Blood Coagulation Tests; Hirudins; Humans; Kinetics; Peptide Fragments; Recombinant Proteins; Sulfones; Thrombin | 1997 |
The importance of enzyme inhibition kinetics for the effect of thrombin inhibitors in a rat model of arterial thrombosis.
Topics: Amino Acid Chloromethyl Ketones; Animals; Anticoagulants; Arginine; Azetidines; Benzylamines; Carotid Artery Thrombosis; Dose-Response Relationship, Drug; Fibrinolytic Agents; Glycine; Hemodynamics; Heparin; Hirudin Therapy; Hirudins; Kinetics; Male; Oligopeptides; Partial Thromboplastin Time; Peptide Fragments; Pipecolic Acids; Piperidines; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Sulfonamides; Thrombin; Thrombin Time | 1997 |
Formulation and Characterization of Antithrombin Perfluorocarbon Nanoparticles.
Topics: Amino Acid Chloromethyl Ketones; Antithrombins; Fluorocarbons; Hirudins; Magnetic Iron Oxide Nanoparticles; Nanoparticles; Particle Size; Peptide Fragments; Polyhydroxyethyl Methacrylate; Recombinant Proteins | 2020 |